Skip to main content
Erschienen in: Heart and Vessels 2/2024

16.10.2023 | Original Article

Atrial electrical remodeling and function after transcatheter aortic valve replacement in patients with aortic stenosis

verfasst von: Yujiro Homma, Minoru Takahashi, Koichi Fuse, Yuki Okamoto, Kazuo Yamamoto, Atsushi Kuwabara, Masaaki Okabe, Shinpei Yoshii, Kiminori Kato, Kohei Akazawa, Yoshifusa Aizawa

Erschienen in: Heart and Vessels | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

To examine reverse atrial electrical remodeling in patients with aortic stenosis (AS) after trans-catheter aortic valve replacement (TAVR). In 65 consecutive patients with severe AS (83 ± 4 years, 47 (72.3%) females), we analyzed ECG records for the P wave duration (PWD) in lead II and P-terminal force (PTFV1) in V1, and measured cardiac dimensions and function by echocardiography (ECHO) following TAVR. Biomarkers were measured to assess myocardial injury by TAVR. TAVR was successfully performed without major complications: the aortic valve area increased from 0.62 ± 0.14 cm2 to 1.52 ± 0.24cm2, and the trans-aortic pressure gradient decreased from 58.4 ± 15.9 mmHg to 15.0 ± 19.6 mmHg. PWD and PTFV increased immediately after TAVR and returned to the pre-TAVR levels on the next day. Then, the PWD declined toward 6 months after TAVR non-significantly in all patients, but significantly in 25 patients with baseline PWD ≥ 130 ms (P = 0.039). PTFV1 showed no long-term change. Improvement was observed in the ejection fraction, all thickness of the left ventricle and in the left atrial dimensions on ECHO. After recovery from transient aggravation by TAVR procedure, PWD reversed slowly, and the change was significant in those with baseline PWD ≥ 130 ms while change in PTFV1 was not significant at 6 months of follow-up. ECHO showed a reversal of remodeling in the left ventricle and in the left atrial dimension after TAVR.
Literatur
1.
Zurück zum Zitat Banovic M, Putnik S, Penicka M, Doros G, Deja MA, Kockova R, Kotrc M, Glaveckaite S, Gasparovic H, Pavlovic N, Velicki L, Salizzoni S, Wojakowski W, Van Camp G, Nikolic SD, Iung B, Bartunek J, AVATAR Trial Investigators* (2022) Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial. Circulation 145:648–658CrossRefPubMed Banovic M, Putnik S, Penicka M, Doros G, Deja MA, Kockova R, Kotrc M, Glaveckaite S, Gasparovic H, Pavlovic N, Velicki L, Salizzoni S, Wojakowski W, Van Camp G, Nikolic SD, Iung B, Bartunek J, AVATAR Trial Investigators* (2022) Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial. Circulation 145:648–658CrossRefPubMed
2.
Zurück zum Zitat Charlson E, Legedza AT, Hamel MB (2006) Decision making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 15:312–321PubMed Charlson E, Legedza AT, Hamel MB (2006) Decision making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 15:312–321PubMed
3.
Zurück zum Zitat Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, Trial Investigators PARTNER (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198CrossRefPubMed Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, Trial Investigators PARTNER (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198CrossRefPubMed
4.
Zurück zum Zitat Writing Committee Members, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C (2021) 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77:450–500CrossRef Writing Committee Members, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C (2021) 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77:450–500CrossRef
5.
Zurück zum Zitat Miura M, Shirai S, Uemura Y, Jinnouchi H, Morinaga T, Isotani A, Watanabe S, Hayashi M, Kamioka N, Nagawawa A, Kakumoto S, Seo K, Arai Y, Hanyu M, Ando K (2017) Early safety and efficacy of transcatheter aortic valve implantation for Asian nonagenarians (from KMH Registry). Int Heart J 58:900–907CrossRefPubMed Miura M, Shirai S, Uemura Y, Jinnouchi H, Morinaga T, Isotani A, Watanabe S, Hayashi M, Kamioka N, Nagawawa A, Kakumoto S, Seo K, Arai Y, Hanyu M, Ando K (2017) Early safety and efficacy of transcatheter aortic valve implantation for Asian nonagenarians (from KMH Registry). Int Heart J 58:900–907CrossRefPubMed
6.
Zurück zum Zitat Kampaktsis NP, Kokkinidis DG, Wong SC, Vavuranakis M, Dkubas NJ, Devereux RB (2017) The role and clinical implications of diastolic dysfunction in aortic stenosis. Heart 103:1481–1478CrossRefPubMed Kampaktsis NP, Kokkinidis DG, Wong SC, Vavuranakis M, Dkubas NJ, Devereux RB (2017) The role and clinical implications of diastolic dysfunction in aortic stenosis. Heart 103:1481–1478CrossRefPubMed
7.
Zurück zum Zitat Gyongyosi M, Winkler J, Ramos I, Gyongyosi M, Do QT, Firat H, McDonald K, Gonzalez A, Thum T, Diez J, Jaisser F, Pizard A, Zannad F (2017) Myocardial fibrosis: biomedical research from bench to bedside. Eur J Heart Fail 19:177–191CrossRefPubMed Gyongyosi M, Winkler J, Ramos I, Gyongyosi M, Do QT, Firat H, McDonald K, Gonzalez A, Thum T, Diez J, Jaisser F, Pizard A, Zannad F (2017) Myocardial fibrosis: biomedical research from bench to bedside. Eur J Heart Fail 19:177–191CrossRefPubMed
8.
Zurück zum Zitat Garg V, Ho JK, Vorobiof G (2017) Change in myocardial deformation after transcatheer and surgical aortic valve replacement. Echocardiography 34:603–613CrossRefPubMed Garg V, Ho JK, Vorobiof G (2017) Change in myocardial deformation after transcatheer and surgical aortic valve replacement. Echocardiography 34:603–613CrossRefPubMed
9.
Zurück zum Zitat Magnani JW, Williamson MA, Ellinor PT, Monahan KM, Benjamin EJ (2009) P wave indices: current status and future directions in epidemiology, clinical and research applications. Circ Arrhythm Electrophysiol 2:72–79CrossRefPubMedPubMedCentral Magnani JW, Williamson MA, Ellinor PT, Monahan KM, Benjamin EJ (2009) P wave indices: current status and future directions in epidemiology, clinical and research applications. Circ Arrhythm Electrophysiol 2:72–79CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Shen MJ, Arora R, Jalife J (2019) Atrial myopathy: JACC basic to translational science. J Am Coll Cardiol 4:640–654 Shen MJ, Arora R, Jalife J (2019) Atrial myopathy: JACC basic to translational science. J Am Coll Cardiol 4:640–654
11.
Zurück zum Zitat Gulsen K, Ince O, Akgun T, Demir S, Uslu A, Kup A, Ocal L, Emiroglu MY, Kargin R, Sahin I, Kepez A, Okuyan E, Ozdemir N, Kaymaz C (2020) The effect of P wave indices on new onset atrial fibrillation after trans-catheter aortic valve replacement. J Electrocardiol 61:71–76CrossRefPubMed Gulsen K, Ince O, Akgun T, Demir S, Uslu A, Kup A, Ocal L, Emiroglu MY, Kargin R, Sahin I, Kepez A, Okuyan E, Ozdemir N, Kaymaz C (2020) The effect of P wave indices on new onset atrial fibrillation after trans-catheter aortic valve replacement. J Electrocardiol 61:71–76CrossRefPubMed
12.
Zurück zum Zitat Sato T, Aizawa Y, Yuasa S, Taya Y (2020) The determinants and outcomes of myocardial injury after transcatheter aortic-valve implantation: SAPIEN 3 study. Cardiovasc Revasc Med 21:973–979CrossRefPubMed Sato T, Aizawa Y, Yuasa S, Taya Y (2020) The determinants and outcomes of myocardial injury after transcatheter aortic-valve implantation: SAPIEN 3 study. Cardiovasc Revasc Med 21:973–979CrossRefPubMed
13.
Zurück zum Zitat Chen LY, Ribeiro ALP, Platonov PG, Cygankiewicz I, Soliman EZ, Gorenek B, Ikeda T, Vassilikos V, Steinberg JS, Varma N, Bayes-de-Luna A, Baranchuk A (2022) P wave parameters and indices: a critical appraisal of clinical utility, challenges, and future research—a consensus document endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrophysiology. Circ Arrhythm Electrophysiol 15:e010435PubMedPubMedCentral Chen LY, Ribeiro ALP, Platonov PG, Cygankiewicz I, Soliman EZ, Gorenek B, Ikeda T, Vassilikos V, Steinberg JS, Varma N, Bayes-de-Luna A, Baranchuk A (2022) P wave parameters and indices: a critical appraisal of clinical utility, challenges, and future research—a consensus document endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrophysiology. Circ Arrhythm Electrophysiol 15:e010435PubMedPubMedCentral
14.
Zurück zum Zitat Yamamoto S, Ono H, Motoyama H, Tachikawa H, Tagawa M, Akazawa K, Aizawa Y (2021) P-wave indices in Japanese patients with ischemic stroke: implication of atrial myopathy in subtype of ischemic stroke. J Electrocardio 66:18–22CrossRef Yamamoto S, Ono H, Motoyama H, Tachikawa H, Tagawa M, Akazawa K, Aizawa Y (2021) P-wave indices in Japanese patients with ischemic stroke: implication of atrial myopathy in subtype of ischemic stroke. J Electrocardio 66:18–22CrossRef
15.
Zurück zum Zitat Lindqvist P, Bajraktari G, Molle R, Palmerini E, Holmgren A, Mondillo S, Henein MY (2010) Valve replacement for aortic stenosis normalizes subendocardial function in patients with normal ejection fraction. Eur J Echocardiogr 11:608–613CrossRefPubMed Lindqvist P, Bajraktari G, Molle R, Palmerini E, Holmgren A, Mondillo S, Henein MY (2010) Valve replacement for aortic stenosis normalizes subendocardial function in patients with normal ejection fraction. Eur J Echocardiogr 11:608–613CrossRefPubMed
16.
Zurück zum Zitat Schattke S, Baldenhofer G, Prauka I, Zhang K, Laule M, Stangl V, Sanad W, Spethmann S, Borges AC, Baumann G, Stangl K, Knebel F (2012) Acute regional improvement of myocardial function after interventional transfemoral aortic valve replacement in aortic stenosis: a speckle tracking echocardiography study. Cardiovasc Ultrasound 10:15CrossRefPubMedPubMedCentral Schattke S, Baldenhofer G, Prauka I, Zhang K, Laule M, Stangl V, Sanad W, Spethmann S, Borges AC, Baumann G, Stangl K, Knebel F (2012) Acute regional improvement of myocardial function after interventional transfemoral aortic valve replacement in aortic stenosis: a speckle tracking echocardiography study. Cardiovasc Ultrasound 10:15CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Delgado M, Ruiz M, Mesa D, Lezo Cruz Conde JS, Pan M, López J, Villanueva E, Cejudo L (2013) Early improvement of the regional and global ventricle function estimated by two-dimensional speckle tracking echocardiography after percutaneous aortic valve implantation speckle tracking after core valve implantation. Echocardiography 30:37–44CrossRefPubMed Delgado M, Ruiz M, Mesa D, Lezo Cruz Conde JS, Pan M, López J, Villanueva E, Cejudo L (2013) Early improvement of the regional and global ventricle function estimated by two-dimensional speckle tracking echocardiography after percutaneous aortic valve implantation speckle tracking after core valve implantation. Echocardiography 30:37–44CrossRefPubMed
18.
Zurück zum Zitat Carasso S, Cohen O, Mutlak D, Adler Z, Lessick J, Aronson D, Reisner SA, Rakowski H, Bolotin G, Agmon Y (2011) Relation of myocardial mechanics in severe aortic stenosis to left ventricular ejection fraction and response to aortic valve replacement. Am J Cardiol 107:1052–1057CrossRefPubMed Carasso S, Cohen O, Mutlak D, Adler Z, Lessick J, Aronson D, Reisner SA, Rakowski H, Bolotin G, Agmon Y (2011) Relation of myocardial mechanics in severe aortic stenosis to left ventricular ejection fraction and response to aortic valve replacement. Am J Cardiol 107:1052–1057CrossRefPubMed
19.
Zurück zum Zitat Løgstrup BB, Andersen HR, Thuesen L, Christiansen EH, Terp K, Klaaborg KE, Poulsen SH (2013) Left ventricular global systolic longitudinal deformation and prognosis 1 year after femoral and apical transcatheter aortic valve implantation. J Am Soc Echocardiogr 26:246–254CrossRefPubMed Løgstrup BB, Andersen HR, Thuesen L, Christiansen EH, Terp K, Klaaborg KE, Poulsen SH (2013) Left ventricular global systolic longitudinal deformation and prognosis 1 year after femoral and apical transcatheter aortic valve implantation. J Am Soc Echocardiogr 26:246–254CrossRefPubMed
20.
Zurück zum Zitat Spethmann S, Baldenhofer G, Dreger H, Stüer K, Sanad W, SaghabalyanD ME, Stangl V, Baumann G, Stangl K (2014) Recovery of left ventricular and left atrial mechanics in various entities of aortic stenosis 12 months after TAVI. Eur Heart J Cardiovasc Imaging 15:389–398CrossRefPubMed Spethmann S, Baldenhofer G, Dreger H, Stüer K, Sanad W, SaghabalyanD ME, Stangl V, Baumann G, Stangl K (2014) Recovery of left ventricular and left atrial mechanics in various entities of aortic stenosis 12 months after TAVI. Eur Heart J Cardiovasc Imaging 15:389–398CrossRefPubMed
21.
Zurück zum Zitat Becker M, Kramann R, Dohmen G, Lückhoff A, Autschbach R, Kelm M, Hoffmann R (2007) Impact of left ventricular loading conditions on myocardial deformation parameters: analysis of early and late changes of myocardial deformation parameters after aortic valve replacement. J Am Soc Echocardiogr 20:681–689CrossRefPubMed Becker M, Kramann R, Dohmen G, Lückhoff A, Autschbach R, Kelm M, Hoffmann R (2007) Impact of left ventricular loading conditions on myocardial deformation parameters: analysis of early and late changes of myocardial deformation parameters after aortic valve replacement. J Am Soc Echocardiogr 20:681–689CrossRefPubMed
22.
Zurück zum Zitat Spethmann S, Dreger H, Baldenhofer G, Stuler K, Saghabalyan D, Mueller E, Haettach R, Stangle V, Laule M, Baumann G, Stangel K, Knebel F (2013) Short-term effects of transcatheter aortic valve implantation on left atrial mechanics and left ventricular diastolic function. J Am Soc Echocardiogr 26:64-71.e2CrossRefPubMed Spethmann S, Dreger H, Baldenhofer G, Stuler K, Saghabalyan D, Mueller E, Haettach R, Stangle V, Laule M, Baumann G, Stangel K, Knebel F (2013) Short-term effects of transcatheter aortic valve implantation on left atrial mechanics and left ventricular diastolic function. J Am Soc Echocardiogr 26:64-71.e2CrossRefPubMed
23.
Zurück zum Zitat D’Ascenzi F, Cameli M, Henein M, Iadanza A, Reccia R, Lisi M, Curci V, Sinicropi G, Torrisi A, Pierli C (2013) Left atrial remodeling in patients undergoing transcatheter aortic valve implantation: a speckle-tracking prospective, longitudinal study. Int J Cardiovasc Imaging 29:1717–1724CrossRefPubMed D’Ascenzi F, Cameli M, Henein M, Iadanza A, Reccia R, Lisi M, Curci V, Sinicropi G, Torrisi A, Pierli C (2013) Left atrial remodeling in patients undergoing transcatheter aortic valve implantation: a speckle-tracking prospective, longitudinal study. Int J Cardiovasc Imaging 29:1717–1724CrossRefPubMed
24.
Zurück zum Zitat D’Andrea A, Padalino R, Cocchia R, Palma ED, Rioegler L, Scarafile R, Rossi G, Bianchi R, Tartaglione D, Bigazzi MC, Calabro P, Citro R, Bossone E, Calabro R, Russo MG (2015) Effects of transcatheter aortic valve implantation o left ventricular and left atrial morphology and function. Echocardiography 32:928–936CrossRefPubMed D’Andrea A, Padalino R, Cocchia R, Palma ED, Rioegler L, Scarafile R, Rossi G, Bianchi R, Tartaglione D, Bigazzi MC, Calabro P, Citro R, Bossone E, Calabro R, Russo MG (2015) Effects of transcatheter aortic valve implantation o left ventricular and left atrial morphology and function. Echocardiography 32:928–936CrossRefPubMed
25.
Zurück zum Zitat Magalhaes MA, Koifman E, Torguson R, Minha S, Gai J, Kiramijyan S, Escarcega RO, Baker NC, Wang Z, Goldstein S, Asch F, Satler LF, Pichard AD, Waksman R (2015) Outcome of left-sided cardiac remodeling in severe aortic stenosis patients undergoing transcatheter aortic valve implantation. Am J Cardiol 116:595–603CrossRefPubMed Magalhaes MA, Koifman E, Torguson R, Minha S, Gai J, Kiramijyan S, Escarcega RO, Baker NC, Wang Z, Goldstein S, Asch F, Satler LF, Pichard AD, Waksman R (2015) Outcome of left-sided cardiac remodeling in severe aortic stenosis patients undergoing transcatheter aortic valve implantation. Am J Cardiol 116:595–603CrossRefPubMed
26.
Zurück zum Zitat Dursun H, Tanriverdi Z, Colluoglu T, Kaya D (2015) Effect of transcatheter aortic valve replacement on P-wave duration, P-wave dispersion and left atrial size. J Geriatr Cardiol 12:613–617PubMedPubMedCentral Dursun H, Tanriverdi Z, Colluoglu T, Kaya D (2015) Effect of transcatheter aortic valve replacement on P-wave duration, P-wave dispersion and left atrial size. J Geriatr Cardiol 12:613–617PubMedPubMedCentral
27.
Zurück zum Zitat Sinning JM, Scheer AC, Adenauer V, Ghanem A, Hammerstingl C, Schueler R, Mulledr C, Vasa-Nicotera M, Grube E, Nickenig G, Werner N (2012) Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 33:1459–1468CrossRefPubMed Sinning JM, Scheer AC, Adenauer V, Ghanem A, Hammerstingl C, Schueler R, Mulledr C, Vasa-Nicotera M, Grube E, Nickenig G, Werner N (2012) Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 33:1459–1468CrossRefPubMed
28.
Zurück zum Zitat Zawadzki G, Radziejwska J, Wollff P, Stawut A, Gajek J, Zawadzki J (2021) The P wave dispersion-one pixel, one millisecond. Rev Cardiovasc Med 22:1633–1640CrossRefPubMed Zawadzki G, Radziejwska J, Wollff P, Stawut A, Gajek J, Zawadzki J (2021) The P wave dispersion-one pixel, one millisecond. Rev Cardiovasc Med 22:1633–1640CrossRefPubMed
Metadaten
Titel
Atrial electrical remodeling and function after transcatheter aortic valve replacement in patients with aortic stenosis
verfasst von
Yujiro Homma
Minoru Takahashi
Koichi Fuse
Yuki Okamoto
Kazuo Yamamoto
Atsushi Kuwabara
Masaaki Okabe
Shinpei Yoshii
Kiminori Kato
Kohei Akazawa
Yoshifusa Aizawa
Publikationsdatum
16.10.2023
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 2/2024
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-023-02321-1

Weitere Artikel der Ausgabe 2/2024

Heart and Vessels 2/2024 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.